Keywords = Prognosis
EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study

Volume 90, Issue 3, March 2022, Pages 113-119

RASHA R. MOSTAFA, M.D.; MOHAMED S. NEGM, M.D.; SAMAR I. AMER, M.D.


Prognostic Value of Soluble Programmed Death Ligand-1 (sPD-L1) in Hepatocellular Carcinoma

Volume 90, Issue 3, March 2022, Pages 153-158

HATEM S. ALEGAILY, M.D.; ADEL M. AGHA, M.D.; AMIRA I. MANSOUR, M.D.


Role of Multi-Pamatric MRI in Loco-Regional Staging ofProstatic Cancer

Volume 89, March, March 2021, Pages 273-277

HALA M. AHMED, M.D.; AHMED E. EBEED, M.D.; AHMED H. MHSB, M.Sc.; AHMED A. ABDEL RAZEK, M.D.; MOHAMED ABOU EL-GHAR, M.D.


Clinicopathological Significance of BRAF V600E Mutation in Egyptian Colorectal Cancer Patients

Volume 88, June, June 2020, Pages 991-997

MONA A. KORA, M.Sc.; NANSY Y. ASAAD, M.D.; HALA S. EL-REBEY, M.D.; RANIA A. HASSANIN, M.D.; ALSHIMAA M. ALHANAFY, M.D.


Immunohistochemical Study of KPNA2 Expression in Correlation to PCNA Expression in Colorectal Carcinoma

Volume 87, September, September 2019, Pages 2993-3001

MARYAM E. ABDO, M.Sc.; HEBA F. HARRAS, M.D.; OMNIA K. RIZK, M.D.; KHAIRIA GAWEESH, M.D.


Factors Influencing Aphasia Outcome in Patients with Occlusive Stroke

Volume 87, September, September 2019, Pages 3977-3983

ESAM M. ELSHAZLY, M.Sc.; OSAMA A. RAGAB, M.D.; AYMAN M. ALMALT, M.D.; DINA M. MOHAMED, M.D.; AHMED M. ELSHAMY, M.D.; EHAB S. MOHAMMED, M.D.


Histopathological and Immunohistochemical Study of the Prognostic Significance of Cox2 and CDX2 Expression in the Available Cases of Colorectal Carcinoma

Volume 87, March, March 2019, Pages 71-80

HEND A. EL-REFAEY, M.Sc.; ASMAA E. BEDEER, M.D.; HASSAN T. SHOEIR, M.D.; HUSSEIN M. GHORABA, M.D.